Full-Time

Senior Scientist

Posted on 7/18/2024

Absci

Absci

51-200 employees

Biotech solutions for protein expression and purification

Biotechnology
Healthcare

Compensation Overview

$127k - $165kAnnually

+ Equity Package + Bonus

Senior, Expert

Vancouver, WA, USA

Position is onsite at Absci HQ in Vancouver, WA.

Category
Lab & Research
Interdisciplinary Research
Life Sciences
Required Skills
Communications
Requirements
  • Ph.D. or equivalent advanced degree in Pharmacology, Immunology/Inflammation, Oncology, Physiology, or related disciplines with at least 5+ years of post-PhD academic and / or industry experience in immunology, immune-mediated inflammatory diseases or related field establishing direct experimental experience with complex biology of inflammatory diseases
  • Extensive experience with flow-based in-depth characterization of immune cell populations in blood and tissue samples.
  • Experience with cell-based assays, ELISA, MSD, qPCR, microscopy, histology/pathology (e.g. IF/IHC/ISH).
  • Demonstrated expertise with complex 2D/3D functional cell-based and tissue-based assays to investigate disease biology and PK/PD relationship.
  • Experience with leveraging complex data sets to characterize and establish a drug’s therapeutic mechanisms of action
  • Ability to be hands on and working in the lab, manage scientists, write protocols, execute studies leveraging Absci’s in house capabilities
  • Experience working with project/research teams with functional responsibility to propose strategy, analyze, interpret, and present complex data to inform decisions
  • Ability to collaborate in writing protocols and reports
  • Outstanding communication skills with demonstrated ability to make effective presentations in a broad range of settings
  • Detail-oriented and organized, with strong interpersonal skills for clear and effective communication.
Responsibilities
  • Work in a dynamic and collaborative Disease Biology team that works closely with key stakeholders across our interdisciplinary R&D teams.
  • Coordinate, design, organize & conduct preclinical in vitro, ex vivo and in vivo studies to advance our internal therapeutic programs.
  • Generate, analyze, and interpret complex data, provide evaluation of PK-PD-efficacy relationships, exploration of PD and predictive biomarkers and elucidation of drug’s MoA.
  • Identify and evaluate (new) in vivo models and technologies to enable novel target validation and lead discovery screening, perform lab-based activities to support a variety of research efforts towards MoA understanding and therapeutic lead development.
  • Establish and manage interactions with vendors and CROs and work closely with key expertise areas to generate necessary studies and reagents for in vivo screening.
  • Serve as Disease Biology SME on multiple project teams, conduct and trouble-shoot experiments, analyze and interpret data and work cross functionally with colleagues to identify and mitigate risks and effectively advance therapeutic programs.
  • Help build complex in vitro and ex vivo research and development capabilities.
  • Author and review clearly articulated SoPs, study reports, and data presentations.

AbSci focuses on improving protein expression and biomanufacturing in the biotech industry. Its main product is an advanced protein expression platform that uses a semi-oxidizing cytoplasm and a dual inducible promoter system, allowing for precise control over protein production. This results in higher quality and efficiency in drug manufacturing. A key feature of AbSci's offerings is SoluPure, a method that simplifies protein purification without chromatography, speeding up the production process and reducing costs. AbSci's workflow can create cell lines that produce active proteins in as little as three months, which is much faster than traditional methods. Unlike its competitors, AbSci aims to replace older mammalian expression systems with its more efficient solutions. The company's goal is to enhance drug discovery and manufacturing processes for pharmaceutical and biotech companies, ultimately transforming the production of biologics.

Company Stage

IPO

Total Funding

$221.7M

Headquarters

Vancouver, Washington

Founded

2011

Growth & Insights
Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

1%
Simplify Jobs

Simplify's Take

What believers are saying

  • Partnership with AMD enhances AI capabilities for drug discovery.
  • Collaboration with MSK accelerates cancer therapeutic development using generative AI.
  • Absci's AI platform achieved breakthroughs in de novo antibody design.

What critics are saying

  • Increased competition from AI-driven drug discovery companies like Insilico Medicine.
  • Regulatory challenges in AI-driven drug discovery could delay approvals.
  • Rapid tech advancements may render current platforms obsolete without continuous innovation.

What makes Absci unique

  • Absci uses deep learning AI and synthetic biology for drug discovery.
  • Their Integrated Drug Creation™ Platform streamlines drug target identification and candidate discovery.
  • SoluPure offers a chromatography-free method, simplifying protein purification processes.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Unlimited Paid Time Off

Parental Leave

401(k) Retirement Plan

401(k) Company Match

Company Equity

Employee Stock Purchase Plan

INACTIVE